Neumora Therapeutics, Inc. · NASDAQ:NMRA
Raymond Debbane's stake in Neumora Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 4, 2026
Raymond Debbane's stake in Neumora Therapeutics, Inc. fell to 4.70%, 8,497,822 shares, as a passive investor on Mar 31, 2026. Filed May 4, 2026 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 8,497,822
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 4.30% | 7,740,030 |
| Invus Public Equities Advisors, LLC | 4.30% | 7,740,030 |
| Invus Global Management, LLC | 4.30% | 7,740,030 |
| Siren, L.L.C. | 4.30% | 7,740,030 |
| Avicenna Life Sci Master Fund LP | 0.40% | 757,792 |
| Avicenna Life Sci Master GP LLC | 0.40% | 757,792 |
| Ulys, L.L.C. | 0.40% | 757,792 |
| Raymond Debbane | 4.70% | 8,497,822 |
Source
Related
- Neumora Therapeutics, Inc.
- Invus Public Equities, L.P.
- Neumora Therapeutics, Inc. shareholders
- Schedule 13G · Invus Public Equities, L.P. · Feb 19, 2026
- Form 4 · Aurora Daljit Singh · Aug 21, 2026
- Form 4 · Aurora Daljit Singh · Aug 19, 2026
- Schedule 13G/A · K2 HealthVentures Equity Trust LLC · May 15, 2026
- Schedule 13D/A · Burow Kristina · Apr 1, 2026
- Schedule 13G/A · K2 HealthVentures Equity Trust LLC · Feb 17, 2026